Related Experiment Videos
Biochemical basis of resistance to chemotherapy
1Institute of Urology, University College London, St. Pauls Hospital, U.K.
Abstract:
Recent progress in the understanding of drug resistance has led to the discovery of new targets for chemotherapy. By attacking the molecules that make cancer cells insensitive to chemotherapy, it is hoped that drug-resistant disease will respond to treatment. This review describes some of the latest advances in understanding of the biochemistry of drug resistance. Following a general introduction four areas of topical interest are discussed: (1) multidrug resistance and P-glycoprotein, (2) glutathione and its related enzymes, (3) topoisomerase II and (4) DNA repair.
Insights
Understanding drug resistance reveals new chemotherapy targets. Attacking molecules causing cancer cell insensitivity aims to treat resistant disease, focusing on P-glycoprotein, glutathione, topoisomerase II, and DNA repair.
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Background:
- Drug resistance is a major challenge in cancer chemotherapy.
- Understanding the biochemical mechanisms of resistance is crucial for developing effective treatments.
Purpose of the Study:
- To review recent advances in the understanding of drug resistance biochemistry.
- To highlight novel molecular targets for overcoming chemotherapy resistance.
Main Methods:
- Literature review of current research on drug resistance.
- Discussion of key molecular mechanisms involved in chemotherapy resistance.
Main Results:
- Advances in understanding multidrug resistance mediated by P-glycoprotein.
- Insights into the role of glutathione and related enzymes in drug detoxification.
- New findings on topoisomerase II as a target in drug resistance.
- Progress in understanding DNA repair mechanisms that contribute to resistance.
Conclusions:
- Targeting specific molecules involved in drug resistance offers a promising strategy for treating resistant cancers.
- Further research into these areas could lead to the development of more effective chemotherapeutic agents.